ABUS Arbutus Biopharma Corp.

Fundamentals / CIK 0001447028 / USD

Arbutus Biopharma Corp. reported $181.5M in revenue and net income of $219.9M for the trailing twelve months ended September 30, 2026 (down 43.5% year over year), with a 81.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABUS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$79.02M$39.51M$0-$362.5MFY 2016 Revenue: $1.49MFY 2016 Net Income: -$384.2M2016FY 2017 Revenue: $10.70MFY 2017 Net Income: -$84.41M2017FY 2018 Revenue: $5.95MFY 2018 Net Income: -$57.06M2018FY 2019 Revenue: $6.01MFY 2019 Net Income: -$153.7M2019FY 2020 Revenue: $6.91MFY 2020 Net Income: -$63.74M2020FY 2021 Revenue: $10.99MFY 2021 Net Income: -$76.25M2021FY 2022 Revenue: $39.02MFY 2022 Net Income: -$69.46M2022FY 2023 Revenue: $18.14MFY 2023 Net Income: -$72.85M2023FY 2024 Revenue: $6.17MFY 2024 Net Income: -$69.92M2024FY 2025 Revenue: $14.08MFY 2025 Net Income: -$33.50M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $14.08M $6.17M $18.14M $39.02M $10.99M $6.91M $6.01M $5.95M $10.70M $1.49M
Research & Development $25.24M $54.04M $73.70M $84.41M $65.50M $49.34M $57.60M $57.93M $62.68M $61.25M
Total Operating Expenses $52.24M $82.49M $96.24M $104.5M $84.51M $64.72M $149.9M $95.72M $121.6M $493.1M
Operating Income -$38.16M -$76.32M -$78.10M -$65.46M -$73.52M -$57.81M -$143.9M -$89.78M -$110.9M -$491.6M
EBITDA -$37.80M -$74.94M -$76.70M -$64.03M -$71.77M -$55.83M -$141.9M -$87.60M -$108.9M -$490.5M
Interest Income $4.07M $6.58M $5.69M $2.19M $127K $741K $2.11M $3.05M $1.54M $1.39M
Interest Expense $97K $137K $459K $1.73M $2.86M $4.01M $2.11M $226K $261K $0
Income Before Tax -- -- -- -- -- -$63.74M -$166.4M -$61.34M -$108.7M -$489.2M
Income Tax Expense $0 $0 $0 $4.44M $0 $0 -$12.66M -$4.28M -$24.32M -$105.0M
Net Income -$33.50M -$69.92M -$72.85M -$69.46M -$76.25M -$63.74M -$153.7M -$57.06M -$84.41M -$384.2M
Basic EPS -$0.17 -$0.38 -$0.44 -$0.46 -$0.83 -$1.00 -$2.89 -$1.21 -$1.56 -$7.24
Diluted EPS -$0.17 -$0.38 -$0.44 -$0.46 -$0.83 -$1.00 -$2.89 -$1.21 -$1.56 -$7.24
Basic Shares Outstanding 191.6M 185.6M 166.0M 150.9M 106.2M 75.8M 57.1M 55.3M 54.7M 53.1M
Diluted Shares Outstanding 191.6M 185.6M 166.0M 150.9M 106.2M 75.8M 57.1M 55.3M 54.7M 53.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $299K $1.01M $179.1M $1.05M $529K $10.74M $1.76M $1.57M
Research & Development $2.62M $2.90M $4.12M $5.01M $5.78M $5.50M $8.96M $8.81M
Total Operating Expenses $10.79M $6.98M $10.22M $6.34M $9.19M $9.25M $27.46M $15.51M
Operating Income -$10.49M -$5.96M $168.9M -$5.29M -$8.66M $1.49M -$25.70M -$13.93M
EBITDA -$10.48M -$5.95M $168.9M -- -$8.65M $1.50M -$25.37M --
Interest Income $2.37M $842K $815K $877K $952K $1.04M $1.20M $1.46M
Interest Expense $11K $18K $17K $18K $23K $28K $28K $30K
Income Tax Expense $0 $0 $0 -- -- -- -- --
Net Income $59.12M -$5.14M $169.7M -$3.76M -$7.74M $2.52M -$24.53M -$12.53M
Basic EPS $0.30 -$0.03 $0.88 -- -$0.04 $0.01 -$0.13 --
Diluted EPS $0.30 -$0.03 $0.87 -- -$0.04 $0.01 -$0.13 --
Basic Shares Outstanding 198.7M 197.5M 193.8M -- 191.8M 191.6M 190.7M --
Diluted Shares Outstanding 199.6M 197.5M 195.2M -- 191.8M 192.4M 190.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.01M $36.33M $26.29M $30.78M $109.3M $52.25M $31.80M $36.94M $54.29M $23.41M
Short-Term Investments $73.46M $86.29M $99.72M $116.1M $46.03M $71.02M $59.03M $87.67M $72.06M $107.1M
Cash & Short-Term Investments $91.50M $122.6M $132.3M $184.3M $191.0M $123.3M $90.83M $124.6M $126.4M $130.6M
Accounts Receivable, Net $1.45M $2.41M $1.78M $1.35M $899K $1.31M $1.20M $1.43M $402K $273K
Total Current Assets $94.46M $127.3M $132.0M $151.1M $160.7M $127.7M $93.83M $129.2M $129.4M $132.6M
Property, Plant & Equipment, Net $32K $3.31M $4.67M $5.07M $5.98M $6.93M $8.68M $10.14M $12.18M $6.95M
Goodwill -- -- -- -- -- -- $0 $22.47M $24.36M $24.36M
Intangible Assets -- -- -- -- -- -- $0 $43.84M $58.65M $99.44M
Long-Term Investments $0 $0 $6.28M $37.36M $35.69M $0 $0 -- $0 $0
Other Non-Current Assets $130K $34K $0 $103K $61K $44K $293K $0 -- --
Total Non-Current Assets $162K $4.39M $12.37M $44.28M $43.82M $9.38M $11.71M $98.68M $107.8M $143.4M
Total Assets $94.62M $131.7M $144.4M $195.4M $204.5M $137.1M $105.5M $227.9M $237.2M $275.9M
Accounts Payable $1.17M $2.32M $3.22M $3.52M $3.17M $2.99M $2.40M $3.19M $1.99M $3.21M
Deferred Revenue (Current) $0 $7.57M $11.79M $16.46M $0 -- -- $0 $2.74M $15K
Total Current Liabilities $6.01M $15.62M $22.49M $32.86M $11.22M $9.54M $7.83M $11.24M $14.63M $10.59M
Long-Term Debt $0 $0 $0 $0 $0 -- -- -- -- --
Deferred Revenue (Non-Current) $0 $2.86M $0 $6.00M $0 -- -- -- $0 $0
Total Non-Current Liabilities $12.04M $18.72M $15.90M $25.71M $23.82M $25.57M $24.96M $16.43M $40.06M $62.33M
Total Liabilities $18.04M $34.34M $38.38M $58.57M $35.05M $35.11M $32.79M $27.67M $54.69M $72.91M
Total Debt (incl. Leases) $746K $1.29M $1.77M $2.19M $2.61M $2.98M $3.36M -- -- --
Common Stock $1.42B $1.41B $1.35B $1.32B $1.29B $985.9M $898.5M $879.4M $876.1M $867.4M
Retained Earnings -$1.38B -$1.35B -$1.28B -$1.20B -$1.13B -$1.05B -$970.1M -$805.2M -$738.1M -$652.7M
Accumulated Other Comp. Income -$48.10M -$48.13M -$48.42M -$50.49M -$48.34M -$48.17M -$48.23M -$48.17M -$48.19M -$48.19M
Total Stockholders' Equity $76.58M $97.37M $106.0M $136.9M $169.4M $102.0M $72.74M $200.2M $182.5M $203.0M
Total Equity $76.58M $97.37M $106.0M $136.9M $169.4M $102.0M $72.74M $200.2M $182.5M $203.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $264.2M $19.17M $23.71M $18.01M $22.41M $37.41M $37.08M $36.33M
Short-Term Investments $73.30M $73.45M $71.52M $73.46M $71.29M $60.68M $75.63M $86.29M
Cash & Short-Term Investments $337.5M $92.62M $95.23M $91.50M $93.70M $98.09M $112.7M $122.6M
Accounts Receivable, Net $792K $369K $1.31M $1.45M $905K $1.02M $1.18M $2.41M
Total Current Assets $339.6M $273.9M $277.0M $94.46M $97.44M $103.1M $116.8M $127.3M
Property, Plant & Equipment, Net $0 $10K $22K $32K $137K $148K $168K $3.31M
Long-Term Investments -- -- -- $0 -- -- -- $0
Other Non-Current Assets $131K $132K $131K $130K $131K $0 $34K $34K
Total Non-Current Assets $131K $142K $153K $162K $268K $148K $202K $4.39M
Total Assets $339.7M $274.0M $277.2M $94.62M $97.71M $103.3M $117.0M $131.7M
Accounts Payable $320K $373K $1.46M $1.17M $1.01M $1.32M $2.24M $2.32M
Deferred Revenue (Current) -- -- -- $0 $0 $0 $6.76M $7.57M
Total Current Liabilities $241.9M $3.36M $5.11M $6.01M $5.18M $5.02M $19.43M $15.62M
Long-Term Debt $0 $0 $0 $0 $0 $0 $0 $0
Deferred Revenue (Non-Current) -- -- -- $0 $0 $0 $2.86M $2.86M
Total Non-Current Liabilities $12.02M $11.93M $11.88M $12.04M $15.13M $15.27M $18.42M $18.72M
Total Liabilities $254.0M $15.29M $16.99M $18.04M $20.31M $20.29M $37.85M $34.34M
Total Debt (incl. Leases) $328K $514K $631K $746K $922K $1.09M $1.19M $1.29M
Common Stock $1.46B $1.45B $1.44B $1.42B $1.42B $1.42B $1.42B $1.41B
Retained Earnings -$1.16B -$1.22B -$1.21B -$1.38B -$1.38B -$1.37B -$1.37B -$1.35B
Accumulated Other Comp. Income -$48.29M -$48.24M -$48.20M -$48.10M -$48.13M -$48.19M -$48.17M -$48.13M
Total Stockholders' Equity $85.75M $258.7M $260.2M $76.58M $77.40M $82.98M $79.16M $97.37M
Total Equity $85.75M $258.7M $260.2M $76.58M $77.40M $82.98M $79.16M $97.37M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$33.50M -$69.92M -$72.85M -$69.46M -$76.25M -$63.74M -$153.7M -$57.06M -$84.41M -$384.2M
Depreciation & Amortization $363K $1.38M $1.40M $1.43M $1.75M $1.98M $2.03M $2.18M $2.03M $1.09M
Stock-Based Compensation $6.95M $8.99M $9.30M $7.18M $6.42M $6.16M $6.80M $6.24M $15.12M $39.16M
Change in Receivables $1.38M -$633K -$424K -$453K $413K -$108K $227K -$1.03M -$129K $735K
Operating Cash Flow -$39.64M -$64.85M -$85.94M -$35.36M -$67.53M -$51.44M -$71.01M -$67.87M -$48.64M -$57.88M
Capital Expenditure $0 -$182K -$1.01M -$512K -$809K -$229K -$589K -$1.14M -$7.26M -$4.00M
Free Cash Flow -$39.64M -$65.03M -$86.94M -$35.87M -$68.34M -$51.67M -$71.59M -$69.00M -$55.90M -$61.88M
Purchases of Investments -$140.1M -$141.5M -$80.51M -$130.4M -$82.22M -$85.58M -$58.76M -$121.6M -- --
Sales & Maturities of Investments $155.3M $164.6M $132.3M $56.00M $70.35M $73.40M $87.67M $118.6M -- --
Investing Cash Flow $15.58M $22.95M $50.77M -$74.94M -$12.68M -$14.91M $28.34M -$4.13M $27.82M -$99.12M
Common Stock Issued -- -- -- -- $134.7M $86.30M $18.60M $0 $0 $0
Financing Cash Flow $5.72M $52.00M $30.65M $31.81M $137.2M $86.75M $37.46M $55.65M $49.32M $12.64M
Net Change in Cash -$18.32M $10.04M -$4.49M -$78.51M $57.03M $20.45M -$5.14M -$17.35M $30.88M -$143.4M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $59.12M -$5.14M $169.7M -$3.76M -$7.74M $2.52M -$24.53M -$12.53M
Depreciation & Amortization $10K $11K $11K -- $11K $11K $330K --
Stock-Based Compensation $1.19M $1.62M $1.36M $1.26M $1.26M $864K $3.56M $1.63M
Change in Receivables -$423K -$82K $1.16M -$129K $120K $157K $1.23M -$801K
Operating Cash Flow $239.8M -$6.02M -$8.11M -$4.68M -$5.82M -$15.75M -$13.39M -$10.31M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$86K
Free Cash Flow -- -- -- -$4.68M -$5.82M -$15.75M -$13.39M -$10.40M
Purchases of Investments -$29.50M -$23.66M -$13.80M -$25.55M -$51.30M -$28.50M -$34.72M -$43.19M
Sales & Maturities of Investments $30.00M $22.00M $16.00M $23.83M $41.28M $44.10M $46.06M $56.69M
Investing Cash Flow $504K -$1.66M $2.20M -$1.36M -$10.02M $15.61M $11.35M $13.41M
Financing Cash Flow $4.71M $3.15M $11.62M $1.64M $844K $453K $2.78M $1.42M
Net Change in Cash $245.0M -$4.54M $5.70M -$4.40M -$15.00M $336K $746K $4.48M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -271.0% -1236.7% -430.5% -167.8% -669.1% -836.1% -2394.0% -1510.2% -1036.7% -32973.8%
Net Profit Margin -237.9% -1133.0% -401.6% -178.0% -693.9% -922.0% -2557.4% -959.8% -788.9% -25765.5%
Return on Equity (ROE) -43.7% -71.8% -68.7% -50.8% -45.0% -62.5% -211.3% -28.5% -46.3% -189.2%
Return on Assets (ROA) -35.4% -53.1% -50.4% -35.5% -37.3% -46.5% -145.7% -25.0% -35.6% -139.2%
Current Ratio 15.73x 8.15x 5.87x 4.60x 14.32x 13.38x 11.99x 11.50x 8.84x 12.52x
Quick Ratio 15.48x 8.00x 5.96x 5.65x 17.10x 13.06x 11.76x 11.22x 8.67x 12.36x
Debt to Equity 0.01x 0.01x 0.02x 0.02x 0.02x 0.03x 0.05x -- -- --
Revenue Growth (YoY) +128.2% -66.0% -53.5% +255.1% +58.9% +15.0% +1.1% -44.4% +617.6% -93.6%
5Y Revenue / Share Growth -19.4% -68.4% +1.7% +32.2% +268.2% -82.2% -84.8% -89.4% -81.0% -98.1%
10Y Revenue / Share Growth -85.6% -95.2% -89.2% -74.8% -93.0% -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -- -171.5% --
10Y Net Income / Share Growth -- -- -- -121.3% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin 81.1% 82.0% 81.7% -271.0% -320.4% -386.5% -1290.9% -1236.7%
Net Profit Margin 121.2% 84.2% 84.0% -237.9% -289.4% -351.9% -1195.9% -1133.0%
Return on Equity (ROE) 256.5% 59.2% 61.8% -43.7% -54.6% -65.4% -96.7% -71.8%
Return on Assets (ROA) 64.7% 55.9% 58.0% -35.4% -43.3% -52.5% -65.4% -53.1%
Current Ratio 1.40x 81.42x 54.26x 15.73x 18.80x 20.53x 6.01x 8.15x
Quick Ratio 1.40x 27.64x 18.91x 15.48x 18.25x 19.74x 5.86x 8.00x
Debt to Equity 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.02x 0.01x
Revenue Growth (YoY) -43.5% -90.6% +10054.5% -33.2% -60.5% +522.2% +15.1% -26.6%
Operating Income Growth (YoY) -- -500.8% -- -- -- -- -- --
Net Income Growth (YoY) -- -303.8% -- -- -- -- -- --
EPS Growth (YoY) -- -400.0% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001447028) · from December 31, 2011 Data through September 30, 2026 · synced Nov 20, 2026, 05:32 UTC · Open in terminal